BioMarin Pharma (NASDAQ: BMRN) announced the introduction of kNOWyourDuchenne, a program to help families and physicians obtain and interpret genetic ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE